BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18946956)

  • 1. Anti-D immunisation with permanent biological damage following inadequate post-amniocentesis prophylaxis.
    Vecchio S; La Scala P; Perri L; Burgo T; Ferrise MA; Caparello S; Sofi S
    Blood Transfus; 2008 Apr; 6(2):112-3. PubMed ID: 18946956
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis.
    Tabsh KM; Lebherz TB; Crandall BF
    Am J Obstet Gynecol; 1984 May; 149(2):225-6. PubMed ID: 6326576
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe neonatal hyporegenerative anemia due to anti-Vw (anti-MNS9) alloantibody.
    Waldvogel S; Natterer J; Canellini G; Truttmann A; Tissot JD
    J Perinat Med; 2009; 37(4):422-4. PubMed ID: 19292586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rhesus-prophylaxis during interventions in early pregnancy].
    Beck A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):613-8. PubMed ID: 6420996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemolytic disease of the newborn due to anti-Ce.
    Malde R; Stanworth S; Patel S; Knight R
    Transfus Med; 2000 Dec; 10(4):305-6. PubMed ID: 11123814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn].
    Lynen R; Neuhaus R; Simson G; Riggert J; Köhler M
    Beitr Infusionsther Transfusionsmed; 1994; 32():203-7. PubMed ID: 9480088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rh(D) haemolytic disease of the newborn: the changing scene.
    Urbaniak SJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immune cytopenias in newborns].
    Brossard Y
    Rev Prat; 2001 Sep; 51(14):1571-6. PubMed ID: 11757274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
    Bowman JM
    Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunization hemolytic disease of the newborn (HDN) Rh with anti-D immunoglobulins].
    Moggian G; Tamburini E
    Ann Sclavo; 1974; 16(1):91-100. PubMed ID: 4214488
    [No Abstract]   [Full Text] [Related]  

  • 12. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho(D) immune globulin. When to use it in the Rho(D)-negative woman.
    Lavery JP
    Postgrad Med; 1984 Mar; 75(4):259-64. PubMed ID: 6322145
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of rhesus immunisation after genetic amniocentesis.
    Tabor A; Jerne D; Bock JE
    Br Med J (Clin Res Ed); 1986 Aug; 293(6546):533-6. PubMed ID: 3092903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 16. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irregular erythrocyte antibodies during pregnancy].
    van Dijk BA; Overbeeke MA; Bennebroek Gravenhorst J
    Ned Tijdschr Geneeskd; 1985 Jul; 129(29):1361-4. PubMed ID: 4033818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of Rhesus isoimmunization. Viewpoint of the obstetrician].
    Langer B
    Arch Pediatr; 1998 Nov; 5(11):1269-73. PubMed ID: 9853068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.